Top compounds associated with response to RMDN1


Feature Type Standardized
Nominal ANOVA
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.091 0.02
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.071 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.02
mRNA XMD14-99 GDSC1000 pan-cancer AAC -0.075 0.02
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.084 0.02
mRNA KIN001-266 GDSC1000 pan-cancer AAC -0.076 0.03
Download CSV